Metis TechBio Co., Ltd. (HKG:7666)
Hong Kong · Delayed Price · Currency is HKD 9.65
-0.55 (-5.39%)
Jul 30, 2026, 4:08 PM HKT
Metis TechBio Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Cash & Equivalents | 828.26 | 557.64 | 561.47 | 364.47 |
Short-Term Investments | 267.18 | 21.44 | 279.58 | 20 |
Trading Asset Securities | 30.06 | 209.1 | - | 20.05 |
Cash & Short-Term Investments | 1,126 | 788.18 | 841.05 | 404.52 |
Cash Growth | 42.80% | -6.29% | 107.92% | - |
Accounts Receivable | 0.18 | 0.27 | 0.71 | - |
Other Receivables | 0.44 | 3.33 | 175.61 | 5.43 |
Receivables | 0.62 | 3.59 | 176.31 | 5.43 |
Restricted Cash | - | - | - | 0.71 |
Other Current Assets | 22.82 | 27.68 | 9.03 | 9.3 |
Total Current Assets | 1,149 | 819.46 | 1,026 | 419.96 |
Property, Plant & Equipment | 93.67 | 72.98 | 105.57 | 173.25 |
Long-Term Investments | - | 107.96 | 125.45 | 10 |
Other Intangible Assets | 4.26 | 5.09 | 6.4 | 1.49 |
Other Long-Term Assets | 43.4 | 43.05 | 49.6 | 12.27 |
Total Assets | 1,290 | 1,049 | 1,313 | 616.98 |
Liabilities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Accounts Payable | 10.61 | 10.69 | 9.36 | 9.61 |
Accrued Expenses | 43.84 | 21.28 | 36.96 | 14.42 |
Current Portion of Long-Term Debt | 40 | 10 | 30 | 571.85 |
Current Portion of Leases | 18.98 | 16.42 | 17.4 | 1.38 |
Current Income Taxes Payable | 0.6 | 0.61 | 1.77 | 0.86 |
Current Unearned Revenue | 49.19 | 48.08 | - | 4.01 |
Other Current Liabilities | 8.99 | 2.35 | 2.73 | 7.27 |
Total Current Liabilities | 172.21 | 109.43 | 98.21 | 609.4 |
Long-Term Leases | 72.15 | 66.6 | 81.81 | 97.7 |
Long-Term Unearned Revenue | 5.05 | 4.66 | 37.81 | - |
Other Long-Term Liabilities | - | 2,250 | 2,073 | - |
Total Liabilities | 249.41 | 2,431 | 2,291 | 707.11 |
Shareholders' Equity
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Common Stock | 94.11 | 87.85 | 87.68 | 111.92 |
Retained Earnings | -1,750 | -1,682 | -1,183 | -601.09 |
Treasury Stock | -15.5 | -2,028 | -2,021 | - |
Comprehensive Income & Other | 2,712 | 2,240 | 2,138 | 399.04 |
Shareholders' Equity | 1,041 | -1,382 | -977.56 | -90.13 |
Total Liabilities & Equity | 1,290 | 1,049 | 1,313 | 616.98 |
Additional Metrics
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Total Debt | 131.13 | 93.02 | 129.21 | 670.93 |
Net Cash (Debt) | 994.37 | 695.17 | 711.84 | -266.41 |
Net Cash Growth | 43.04% | -2.34% | - | - |
Net Cash Per Share | 11.82 | 8.87 | 8.83 | -2.50 |
Filing Date Shares Outstanding | 1,153 | 79.81 | 80.64 | 106.39 |
Total Common Shares Outstanding | 94.11 | 79.81 | 80.64 | 106.39 |
Working Capital | 976.74 | 710.03 | 928.17 | -189.44 |
Book Value Per Share | 11.06 | -17.32 | -12.12 | -0.85 |
Tangible Book Value | 1,037 | -1,387 | -983.96 | -91.62 |
Tangible Book Value Per Share | 11.02 | -17.39 | -12.20 | -0.86 |
Machinery | 74.91 | 74.59 | 70.38 | 43.89 |
Construction In Progress | 20.94 | - | 1.4 | 36.54 |
Leasehold Improvements | 54.45 | 53.39 | 55.14 | 18.01 |